Cargando…
P256 Impact of COVID-19 pandemic and introduction of CFTR modulator therapy on sputum sampling in a large adult cystic fibrosis (CF) unit
Autores principales: | Gaffney, K., Pollard, K., Etherington, C., Saumtally, H., Denton, M., Clifton, I.J., Peckham, D.G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Cystic Fibrosis Society. Published by Elsevier B.V.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10250888/ http://dx.doi.org/10.1016/S1569-1993(23)00628-8 |
Ejemplares similares
-
Different CFTR modulator combinations downregulate inflammation differently in cystic fibrosis
por: Jarosz-Griffiths, Heledd H, et al.
Publicado: (2020) -
Cytomegalovirus-associated pulmonary exacerbation in patients with cystic fibrosis
por: Sawant, Akhil, et al.
Publicado: (2018) -
ePS4.05 Evolving cystic fibrosis care during COVID-19: a single-centre experience
por: Spoletini, G., et al.
Publicado: (2022) -
Urinary bicarbonate and metabolic alkalosis during exacerbations in cystic fibrosis
por: Spoletini, Giulia, et al.
Publicado: (2022) -
Connexin 37 and Connexin 43 genotypes in correlation to cytokines in induced sputum and blood in cystic fibrosis (CF)
por: Ludwig, M, et al.
Publicado: (2014)